Exane Derivatives’s Canopy Growth CGC Stock Holding History

Exane Derivatives’s Portfolio CGC Stock Details CGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-73	Closed	-$5.53K	–	828
2022 Q1	$5.53K	Sell	73 -8,900	-99%	-$679K	﹤0.01%	693
2021 Q4	$783K	Buy	8,973 +8,900	+12,192%	+$1.06M	0.19%	118
2021 Q3	$10.1K	Hold	73	–	–	﹤0.01%	707
2021 Q2	$16.1K	Hold	73	–	–	﹤0.01%	726
2021 Q1	$23.3K	Sell	73 -19	-21%	-$6.72K	0.01%	561
2020 Q4	$22.5K	Sell	92 -619	-87%	-$141K	0.01%	507
2020 Q3	$102K	Hold	711	–	–	0.03%	295
2020 Q2	$115K	Buy	711 +606	+577%	+$98.1K	0.03%	278
2020 Q1	$15.2K	Sell	105 -6,694	-98%	-$1.26M	﹤0.01%	415
2019 Q4	$1.69M	Buy	6,799 +2,838	+72%	+$563K	0.31%	89
2019 Q3	$909K	Buy	3,961 +2,386	+151%	+$730K	0.16%	111
2019 Q2	$635K	Buy	1,575 +244	+18%	+$107K	0.11%	146
2019 Q1	$577K	Buy	+1,331	New	+$583K	0.11%	146
2018 Q4	–	Sell	-230	Closed	-$117K	–	690
2018 Q3	$117K	Buy	+230	New	+$85K	0.02%	301

Other funds holding CGC

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Exane Derivatives's CGC Position: Q2 2022 in Review

Exane Derivatives sold out of Canopy Growth (CGC) in Q2 2022, closing a stake of 73 shares — an estimated $5.53K sold.

Exane Derivatives first reported a position in CGC in Q3 2018 and held it in 14 quarters. The position peaked at $1.69M in Q4 2019. 367 funds tracked by Wall St. Rank hold CGC as of Q2 2022.

Exane Derivatives reported no remaining Canopy Growth position as of Q2 2022 after selling out during the quarter.
Exane Derivatives sold 73 Canopy Growth shares in Q2 2022, an estimated $5.53K.
Exane Derivatives first reported a position in Canopy Growth in Q3 2018 and held it in 14 quarters.
Exane Derivatives's Canopy Growth position peaked at $1.69M in Q4 2019.
367 funds tracked by Wall St. Rank held Canopy Growth as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.